Literature DB >> 23666295

Epidemiology of atrial fibrillation in Turkey: preliminary results of the multicenter AFTER study.

Faruk Ertaş1, Hasan Kaya, Zekeriya Kaya, Serkan Bulur, Nuri Köse, Mehmet Gül, Nihan Kahya Eren, Cağlar Emre Cağlıyan, Bayram Köroğlu, Bülent Vatan, Göksel Acar, Murat Yüksel, Mehmet Zihni Bilik, Selçuk Gedik, Ziya Simşek, Mehmet Ata Akıl, Rüstem Yılmaz, Mustafa Oylumlu, Alpay Arıbaş, Abdulkadir Yıldız, Mesut Aydın, Ekrem Yeter, Mehmet Kanadaşı, Oktay Ergene, Hakan Ozhan, Mehmet Sıddık Ulgen.   

Abstract

OBJECTIVES: Although atrial fibrillation (AF) is one of the most common rhythm disorders observed in clinical practice, a multicenter epidemiological study has not been conducted in our country. This study aimed to assess our clinical approach to AF based upon the records of the first multicenter prospective Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER) study. STUDY
DESIGN: Taking into consideration the distribution of the population in our country, 2242 consecutive patients with at least one AF attack determined by electrocardiographic examination in 17 different tertiary health care centers were included in the study. Inpatients and patients that were admitted to emergency departments were excluded from the study. Epidemiological data of the patients and the treatment administered were assessed.
RESULTS: The mean age of the patients was determined as 66.8 ± 12.3 years with female patients representing 60% of the study population. While the most common AF type in the Turkish population was non-valvular AF (78%), persistent/permanent AF was determined in 81% of all patients. Hypertension (%67) was the most common co-morbidity in patients with AF. While a stroke or transient ischemic attack or history of systemic thromboembolism was detected in 15.3% of the patients, bleeding history was recorded in 11.2%. Also, 50% of the patients were on warfarin treatment and 53% were on aspirin treatment at the time of the study. The effective INR level was detected in 41.3% of the patients. The most frequent cause of not receiving anticoagulant therapy was physician neglect.
CONCLUSION: These results demonstrate the necessity for improved quality of physician care of patients with AF, especially with regards to antithrombotic therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666295     DOI: 10.5543/tkda.2013.18488

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  10 in total

1.  New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio.

Authors:  Halit Acet; Faruk Ertaş; Mehmet Ata Akıl; Mustafa Oylumlu; Nihat Polat; Abdulkadir Yıldız; Mehmet Zihni Bilik; Murat Yüksel; Zeynettin Kaya; Mehmet Sıddık Ulgen
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-26       Impact factor: 2.357

2.  Comparison of non-vitamin K antagonist oral anticoagulants and well-controlled warfarin in octogenarians with non-valvular atrial fibrillation: Real-world data from a single tertiary center.

Authors:  Arzu Neslihan Akgün; Emir Karaçağlar; Uğur Abbas Bal; Mehmet Bülent Özin
Journal:  Anatol J Cardiol       Date:  2021-07       Impact factor: 1.596

3.  Comparison of Warfarin use in terms of efficacy and safety in two different polyclinics.

Authors:  Salih Kılıç; Hatice Soner Kemal; Elif İlkay Yüce; Evrim Şimşek; Burcu Yağmur; Nuray Memişoğlu Akgül; Cahide Soydaş Çınar; Mehdi Zoghi; Cemil Gürgün
Journal:  Anatol J Cardiol       Date:  2017-11       Impact factor: 1.596

4.  The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study.

Authors:  Salih Kılıç; Ahmet Çelik; Hüseyin Altuğ Çakmak; Abdülmecit Afşin; Ahmet İlker Tekkeşin; Gönül Açıksarı; Mehmet Erdem Memetoğlu; Fatma Özpamuk Karadeniz; Ekrem Şahan; Mehmet Hayri Alıcı; Yüksel Dereli; Ümit Yaşar Sinan; Mehdi Zoghi
Journal:  Balkan Med J       Date:  2017-04-06       Impact factor: 2.021

5.  ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study).

Authors:  Özcan Başaran; Osman Beton; Volkan Doğan; Mehmet Tekinalp; Ahmet Çağrı Aykan; Ezgi Kalaycıoğlu; İsmail Bolat; Onur Taşar; Özgen Şafak; Macit Kalçık; Mehmet Yaman; İbrahim Altun; Mustafa Özcan Soylu; Cevat Kırma; Murat Biteker
Journal:  Anatol J Cardiol       Date:  2016-10       Impact factor: 1.596

6.  The relationship between atrial electromechanical delay and left atrial mechanical function in stroke patients.

Authors:  Mehmet Ata Akıl; Eşref Akıl; Mehmet Zihni Bilik; Mustafa Oylumlu; Halit Acet; Abdülkadir Yıldız; Abdurrahman Akyüz; Faruk Ertaş; Nizamettin Toprak
Journal:  Anatol J Cardiol       Date:  2014-06-03       Impact factor: 1.596

7.  Design and Rationale of the National Tunisian Registry of Atrial Fibrillation: Protocol for a Prospective, Multicenter Trial.

Authors:  Afef Ben Halima; Sana Ouali; Mohamed Sami Mourali; Sonia Chabrak; Rafik Chettaoui; Manel Ben Halima; Abdeddayem Haggui; Noureddine Larbi; Salma Krichène; Sonia Marrakchi; Slim Kacem; Rim Chrigui; Mohamed Fahmi Abbes; Hédi Baccar; Nadia Baraket; Najeh Ben Halima; Ali Ben Khalfallah; Mohamed Ben Mbarek; Soraya Ben Youssef; Essia Boughzala; Mohamed Rachid Boujnah; Habiba Drissa; Habib Gamra; Ali Gasmi; Habib Haouala; Youssef Harrath; Ines Issa; Gouider Jeridi; Salem Kachboura; Samir Kammoun; Sondes Kraiem; Faouzi Maatouk; Sami Milouchi; Wided Nasraoui; Ali Neji; Khaled Sayahi; Wissem Sdiri; Wajih Smati; Samir Tlili; Leila Abid; Salem Abdesselem; Lilia Zakhama; Abdallah Mahdhaoui; Helmi Kammoun; Skander Ben Omrane; Faouzi Addad
Journal:  JMIR Res Protoc       Date:  2018-10-15

Review 8.  National guidelines on the management of venous thromboembolism: Joint guideline of the Turkish Society of Cardiovascular Surgery, National Society of Vascular and Endovascular Surgery, and Phlebology Society.

Authors:  Ahmet Kürşat Bozkurt; Hakkı Tankut Akay; İsmet Tanzer Çalkavur; Mustafa Şırlak; Ozan Onur Balkanay; Emrah Uğuz; Suat Doğancı; Adil Polat; Serdar Bayrak; Şahin Bozok; Ahmet Barış Durukan; Nevzat Erdil; Dilek Erer; Şahin Şenay; Ertekin Utku Ünal; Soner Yavaş
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

9.  The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR.

Authors:  Ahmet Çelik; Servet İzci; Mehmet Ali Kobat; Ahmet Hakan Ateş; Abdülkadir Çakmak; Yasin Çakıllı; Mehmet Birhan Yılmaz; Mehdi Zoghi
Journal:  Anatol J Cardiol       Date:  2015-11-19       Impact factor: 1.596

10.  The relationship between the nutritional status and sleep quality of patients with atrial fibrillation.

Authors:  Şeyma Şengül; Hilal Uysal
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.